Premium pharmaceutical excipient for direct compression with excellent binding and disintegration properties
Ideal for direct compression processes with excellent compactibility and flow properties.
Superior binding properties ensuring strong tablet integrity and mechanical strength.
Provides controlled disintegration properties for optimal drug release profiles.
Chemically inert with excellent compatibility with various active pharmaceutical ingredients.
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | White, odorless, crystalline powder | Visual |
| Identification | Complies with USP/EP standards | IR Spectroscopy |
| pH (1% slurry) | 5.0 - 7.5 | USP <791> |
| Loss on Drying | ≤ 5.0% | USP <731> |
| Residue on Ignition | ≤ 0.1% | USP <281> |
| Heavy Metals | ≤ 10 ppm | USP <231> |
| Particle Size Distribution | D50: 45-65 μm | Laser Diffraction |
| Bulk Density | 0.26 - 0.31 g/mL | USP <616> |
| Tapped Density | 0.35 - 0.46 g/mL | USP <616> |
| Compressibility Index | ≤ 20% | USP <616> |
| Degree of Polymerization | ≥ 350 | USP Method |
| Microbial Limits | Total Aerobic Count: ≤ 1000 CFU/g Yeast & Mold: ≤ 100 CFU/g |
USP <61> |
Primary application as binder and filler in direct compression tablet formulations.
Excellent for immediate release formulations with controlled disintegration properties.
Compatible with wet granulation processes as a binder and disintegrant.
Provides pleasant mouthfeel and texture in chewable tablet formulations.
Used as diluent and flow aid in capsule formulations for improved processing.
Ideal diluent for low dose active ingredients requiring precise content uniformity.
Our Microcrystalline Cellulose (MCC 101) meets the highest international pharmaceutical standards and regulatory requirements.
United States Pharmacopeia
European Pharmacopoeia
Japanese Pharmacopoeia
Indian Pharmacopoeia
British Pharmacopoeia
Contact us today for quotes, samples, or technical support